High levels of Hsp60 in the plasma and saliva of T2DM patients were detected compared to non-diabetic controls and immunohistochemical analysis in 66 TNBC tissues of Jordanian women that revealed that Hsp60, considered as an inflammatory marker of T2DM, was highly expressed in advanced stage of the tumor, considering Hsp60 as a poor prognosis marker in TNBC patients [51,52,53]. Here, HSPD1 is linked to neoplasm.